Clinical Trials Logo
  1. Home
  2. Malignant Brain Tumor
  3. NCT02880111

Rates DMBT1 ( Glycoprotein) in Sputum of CF Patients With Pseudomonas Aeruginosa — DMBT1  

Malignant Brain Tumor Clinical Trial

Official title:
Comparison of Rates DMBT1 ( Glycoprotein) in Sputum of CF Patients Colonized Patients Between Chronic and Non-chronic Patients Colonized With Pseudomonas Aeruginosa

Clinical Trial Summary

Rates of DMBT1 (Glycoprotein like) in Sputum of CF Patients with or without may be different according to their Pseudomonas Aeruginosa chronic colonization status. The aim of this study is to compare rates of DMBT1 (Glycoprotein like) in Sputum of CF patients with or without a Pseudomonas Aeruginosa chronic colonization.

Clinical Trial Description

Rates of DMBT1 (Deleted in Malignant Brain Tumor 1) will be compared between 2 groups of 30 CF patients : group 1 : with Pseudomonas Aeruginosa chronic colonization and group 2 30 CF patients without Pseudomonas Aeruginosa chronic colonization. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02880111
Study type Observational
Source University Hospital, Lille
Contact
Status Terminated
Phase
Start date March 23, 2016
Completion date March 2022
View Details
See also
  Status Clinical Trial Phase
Completed NCT04109209 - Psychological Intervention For Brain Tumor Caregivers N/A
Completed NCT02798406 - Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects Phase 2
Completed NCT04351035 - National Wide Cross-sectional Study in Paediatric Central Nervous System Tumours in China -- the CNOG-MC001 Registry
Completed NCT02502708 - Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors Phase 1
Recruiting NCT05976490 - NeuroPathways Intervention for Brain Tumor Patients N/A
Terminated NCT02128373 - A Computer-Based Intervention for Distance Caregivers of Parents With Advanced Cancer N/A
Terminated NCT02885324 - Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children Phase 2
Not yet recruiting NCT06099743 - ASCENT Intervention for Brain Tumor Patients N/A
Completed NCT02052648 - Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors Phase 1/Phase 2
Not yet recruiting NCT06098248 - cCeLL - Ex Vivo (Confocal Fluorescence Endomicroscopy) for Intraoperative Brain Tumor Diagnosis N/A
Completed NCT00418327 - Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma Phase 1
Recruiting NCT05293197 - Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumors in Pediatric Patients Phase 1
Recruiting NCT06092125 - Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease
Not yet recruiting NCT05669326 - Evaluation of the Contribution of NODDI Protocol Tractography in Brain Tumor Surgery N/A
Suspended NCT05169944 - Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors Phase 1